Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Today's 3 Best Stocks

Watch stocks you care about

The single, easiest way to keep track of all the stocks that matter...

Your own personalized stock watchlist!

It's a 100% FREE Motley Fool service...

Click Here Now

Volatility is the name of the game yet again today for the broad-based S&P 500 (SNPINDEX: ^GSPC  ) , which is being tossed around like a rag doll following yesterday's huge tumble.

With no economic data on the table today, investors instead chose to focus for a third-straight day on the implication of the Federal Reserve's meeting on Wednesday, which left open the potential for a paring back of its $85 billion monthly bond-buying program before the year is out.

As I've stated before, this has both positive and negative implications. On the plus side, it signals that the economy is strong enough to move forward without the aid of additional stimulus. Conversely, low lending rates have been spurred on by continued monetary easing by the Fed. Without this easing, there's a good chance interest rates will rise -- we've already seen 10-Year U.S. Treasury yields jump 90 basis points in about two months -- and could cause loan activity to slow to a crawl.

After a whipsaw day, the S&P 500 ended higher by 4.24 points (0.27%), to close at 1,591.89. While certainly volatile, three stocks within the S&P 500 had no trouble putting together a solid day for shareholders.

Leading the pack higher was cloud-software solutions company (NYSE: CRM  ) , which advanced 4.2% on a report that it is about to announce a cloud-software alliance with Oracle according to the The New York Times. The deal would be beneficial to both parties, as it would allow data to be easily shared between Oracle and salesforce's software, potentially making both attractive to prospective software clients. It would certainly make sense for Oracle, which missed Wall Street's estimates with its third-quarter results, and disappointed with its fourth-quarter outlook.

Residential real estate investment trust Equity Residential (NYSE: EQR  ) had a particularly good day, jumping by 3.4%. REITs that specialize in apartment community ownership are in fantastic shape if the Fed is thinking about reducing its bond buying. As lending rates rise from less monetary easing, the desire to purchase a home should drop considerably, making apartment living a smart choice. Equity Residential already has high occupancy rates, but, as rates rise, it could see occupancy tick even higher.

Finally, shares of drug maker AbbVie (NYSE: ABBV  ) added 3.8% at the expense of peer Idenix Pharmaceuticals, which imploded after the Food and Drug Administration placed a hold on clinical trials for experimental hepatitis-C drug, IDX20963. The FDA is requesting Idenix supply the agency with additional safety data before it'll let it start clinical trials for IDX20963, placing the company even further behind in the hepatitis-C race. AbbVie, on the other hand, is in great share with its oral hep-c trio performing very in trials and looking like the only serious competitor to Gilead Sciences sofosbuvir -- assuming, of course, that it gets approved. 

If you're looking for some long-term investing ideas, you're invited to check out The Motley Fool's brand-new special report, "The 3 Dow Stocks Dividend Investors Need." It's absolutely free, so simply click here now and get your copy today.

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2503613, ~/Articles/ArticleHandler.aspx, 10/1/2016 11:37:29 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 14 hours ago Sponsored by:
DOW 18,308.15 164.70 0.91%
S&P 500 2,168.27 17.14 0.80%
NASD 5,312.00 42.85 0.81%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/30/2016 5:01 PM
^GSPC $2168.27 Up +17.14 +0.80%
S&P 500 INDEX CAPS Rating: No stars
CRM $71.33 Up +0.13 +0.18% CAPS Rating: ***
EQR $64.33 Down -0.10 -0.16%
Equity Residential CAPS Rating: ***